EpiPen Lawsuit $264 Million Settlement
Originally published by Goldberg Noone Abraham on March 2, 2022. In 2016, the drugmaker Mylan, now known as Viatris Inc, faced widespread public outrage and condemnation due to a dramatic increase in the price of EpiPen allergy treatments, an auto-injectable device that delivers the drug epinephrine for use when experiencing a life-threatening allergic reaction known […]